Zydus Lifesciences (ZYDUSLIFE) — Financial Results

Zydus Lifesciences reported Q1 FY26 consolidated revenue of ₹65.7 billion (up 6% YoY) with net profit of ₹14.7 billion (up 3% YoY) and EBITDA margin of 31.8%. Net cash strengthened to ₹56.3 billion. US formulations grew modestly at 3% YoY, while India grew 6% YoY with branded formulations up 9%. International markets surged 37% YoY. Key developments include completing 85.6% stake in Amplitude Surgical and launching novel Semaglutide formulation in India, with planned capex of ₹1,200 crores for FY26.

📄 View Original Announcement (PDF)

📊 Stock Analysis — ZYDUSLIFE ✨ Ask AI About This

About Zydus Lifesciences Limited (ZYDUSLIFE)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,01,800.69 Cr P/E: 22.5

View full ZYDUSLIFE stock details →

📡 Get AI alerts when ZYDUSLIFE files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track ZYDUSLIFE — Free

💡 Ask AI about this filing

"How does this financial results affect Zydus Lifesciences Limited's outlook?" "What did Zydus Lifesciences Limited announce on 20 August 2025?" "Is this positive or negative for ZYDUSLIFE?"

Ask AI Free →

📊 More ZYDUSLIFE filings

See all ZYDUSLIFE filings →

🔥 Also filed on 20 August 2025

AMBUJACEM Ambuja Cements Limited Corporate Action ULTRACEMCO UltraTech Cement Limited Offer Document ULTRACEMCO UltraTech Cement Limited Offer Document TITAN Titan Company Limited Announcement VEDL Vedanta Limited Announcement APOLLOHOSP Apollo Hospitals Enterprise Limited Financial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when ZYDUSLIFE files new disclosures

Track ZYDUSLIFE filings, board meetings, and corporate actions. Free email alerts at 5 PM.